Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response

PLoS One. 2009 Oct 27;4(10):e7582. doi: 10.1371/journal.pone.0007582.

Abstract

Background: RIG-I is a pivotal receptor that detects numerous RNA and DNA viruses. Thus, its defectiveness may strongly impair the host antiviral immunity. Remarkably, very little information is available on RIG-I single-nucleotide polymorphisms (SNPs) presenting a functional impact on the host response.

Methodology/principal findings: Here, we studied all non-synonymous SNPs of RIG-I using biochemical and structural modeling approaches. We identified two important variants: (i) a frameshift mutation (P(229)fs) that generates a truncated, constitutively active receptor and (ii) a serine to isoleucine mutation (S(183)I), which drastically inhibits antiviral signaling and exerts a down-regulatory effect, due to unintended stable complexes of RIG-I with itself and with MAVS, a key downstream adapter protein.

Conclusions/significance: Hence, this study characterized P(229)fs and S(183)I SNPs as major functional RIG-I variants and potential genetic determinants of viral susceptibility. This work also demonstrated that serine 183 is a residue that critically regulates RIG-I-induced antiviral signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry*
  • Cell Line
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases / genetics*
  • Dimerization
  • Genetic Variation
  • Humans
  • Immune System*
  • Immunity, Innate
  • Models, Genetic
  • Models, Molecular
  • Mutation, Missense
  • Phenotype
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Receptors, Immunologic
  • Signal Transduction

Substances

  • Antiviral Agents
  • Receptors, Immunologic
  • RIGI protein, human
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases